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Abstract
Background: Sufficient levels of physical activity provide cardio-protective benefit. However
within developed society sedentary work and inflexible working hours promotes physical inactivity.
Consequently to ensure a healthy workforce there is a requirement for exercise strategies
adaptable to occupational time constraint. This study examined the effect of a 12 week aerobic
exercise training intervention programme implemented during working hours on the
cardiovascular profile of a sedentary hospital workforce.
Methods: Twenty healthy, sedentary full-time staff members of the North West London Hospital
Trust cytology unit were randomly assigned to an exercise (n = 12; mean ± SD age 41 ± 8 years,
body mass 69 ± 12 kg) or control (n = 8; mean ± SD age 42 ± 8 years, body mass 69 ± 12 kg) group.
The exercise group was prescribed a progressive aerobic exercise-training programme to be
performed 4 times a week for 8 weeks (initial intensity 65% peak oxygen consumption (VO2 peak))
and to be conducted without further advice for another 4 weeks. The control was instructed to
maintain their current physical activity level. Oxygen economy at 2 minutes (2minVO2), 4 minutes
(4minVO2), VO2 peak, systolic blood pressure (SBP), diastolic blood pressure (DBP), BMI, C-reactive
protein (CRP), fasting glucose (GLU) and total cholesterol (TC) were determined in both groups
pre-intervention and at 4 week intervals. Both groups completed a weekly Leisure Time
Questionnaire to quantify additional exercise load.
Results: The exercise group demonstrated an increase from baseline for VO2 peak at week 4 (5.8
± 6.3 %) and 8 (5.0 ± 8.7 %) (P < 0.05). 2minVO2 was reduced from baseline at week 4 (-10.2 ±
10.3 %), 8 (-16.8 ± 10.6 %) and 12 (-15.1 ± 8.7 %), and 4minVO2 at week 8 (-10.7 ± 7.9 %) and 12
(-6.8 ± 9.2) (P < 0.05). There was also a reduction from baseline in CRP at week 4 (-0.4 ± 0.6 mg·L-
1) and 8 (-0.9 ± 0.8 mg·L-1) (P < 0.05). The control group showed no such improvements.
Conclusion: This is the first objectively monitored RCT to show that moderate exercise can be
successfully incorporated into working hours, to significantly improve physical capacity and
cardiovascular health.
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It is widely accepted that cardiovascular disease (CVD) is
the leading cause of death in developed countries [1].
Over the past decade it has become recognised that phys-
ical activity is an independent factor in the determination
of over all CVD risk through the prevention of atheroscle-
rosis and reduction of thrombotic risk [2,3]. Evidence
supports an inverse association between physical fitness
and various CVD risk factors, including glucose tolerance
[4], cholesterol [5], blood pressure [6], resting pulse rate
[7] and obesity [8], and markers of systemic inflammation
including C-reactive protein (CRP) [9], and TNFα [10]. It
is suggested that such effects occur through a reduction in
lipoprotein oxidation [11], improved endothelial func-
tion via the increased production of nitric oxide and pros-
tacyclin [12], decreased atherogenic activity of blood
mononuclear cells effecting the production of cytokines
[13], and a reduced accumulation of collagen in the arte-
rial wall [14]. Therefore guidelines recommend that indi-
viduals accrue 30 minutes of moderate physical activity
on at least 5 days of the week [15,16].
Despite the positive impact of physical fitness on CVD,
developed societies have become more sedentary in both
occupation and leisure time. A recent observational study
of 2595 civil servants in Northern Ireland reported that
almost two thirds failed to engage in regular, moderate
physical activity, with females twice as likely to abstain
from exercise than men [17]. In England it has been
reported that a total of 24.2% of men and 19.8% of
women meet the activity recommendations; a total that
dropped to 17.6% and 13.0% when domestic activity was
excluded [18]. Since most adults will spend more than
half their waking hours within the workplace, worksite
health promotion programs that influence employee
behaviour by promoting physical activity could prove
fundamental in addressing the growing problem of seden-
tary habit and cardiovascular risk.
A number of randomised-controlled trials assessing the
benefit of workplace exercise interventions on health-
related outcome measures (body composition, blood
pressure, lipid profile, inflammatory markers) have been
reported [19-21]. However, the conclusions from these
trials have been based upon the subjective self-report of
physical activity, without individualised prescription or
monitoring of the exercise programme, and objective
assessment. Therefore the relationship between improved
physical capacity and health from workplace exercise
remains inconclusive [21]. In view of this there is a neces-
sity for further studies of strong methodological quality to
examine corporate exercise strategies adaptable to occupa-
tional time constraints.
The aim of this pilot study was to investigate the efficacy
of a structured, monitored 12-week aerobic exercise train-
ing intervention programme on modifying the cardiovas-
cular risk profile of a sedentary National Health Service
(NHS) workforce, and to evaluate whether it could be
implemented during working hours.
Methods
Setting
The trial was conducted at the Olympic Medical Institute
(OMI), Northwick Park and North West London Hospi-
tals (NWLH) NHS Trust (Northwick Park site). The North
West London Research Ethics Committee, NWLH NHS
Trust approved the trial (REC 05/Q0405/122). All partic-
ipants provided written informed consent before entering
the study.
Study participants
Participants were full-time male and female personnel
from the NWLH Trust cytology laboratory. Who as spe-
cialist medical and non-medical cytology staff, spend
multiple hours per day seated for the microscopic assess-
ment of cervical cytology slides. All subjects were defined
"sedentary" from self-reported physical activity levels of
less than 2 hours organised physical activity per week. Eli-
gible participants were not admitted if they had known
cardiac disease, uncontrolled hypertension, thyroid dis-
ease, diabetes, mental illness, infection, immune or endo-
crine abnormality or contraindications to exercise on the
basis of an exercise stress test. All participants were
required to complete a medical screening questionnaire
(PAR-Q) before entering the study.
20 participants were recruited and randomly assigned to
an exercise (n = 12) or control (n = 8) group using a ran-
dom numbers table. Group assignment was revealed fol-
lowing baseline testing.
Experimental design
Physiological tests included blood pressure, body composi-
tion, peak oxygen uptake and blood screening, and were
performed at pre-intervention and at 4 weekly intervals for
a total of 12 weeks. After baseline assessment and at each 4
week reassessment, control subjects were instructed to
maintain their current physical activity level, while the exer-
cise group were provided with an individualised progres-
sive exercise prescription of brisk walking or light jogging to
be performed 4 times a week for the following 4 weeks (Fig-
ure 1.). At 8 weeks no further progression of the exercise
training programme was provided, and participants were
instructed to maintain the exercise as of week 8 for the final
4 weeks. This was to evaluate if there was any further phys-
iological benefit, or if exercise adherence was affected in the
absence of any additional training stimulus. Participants
conducted all exercise sessions during their lunch, morningPage 2 of 10
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laboratory working routine. Heart rate monitors (F4, Polar
electro-oy, Kempele, Finland) were provided to monitor
accurately the intensity of the exercise prescribed, and the
average heart rate and exercise duration of each session was
recorded in an exercise diary. The exercise intensity was ini-
tially set to correspond with 65 % of peak oxygen consump-
tion (VO2 peak). Participants were instructed on an
appropriate warm-up and cool-down procedure, and pro-
vided with a supervised exercise session during the initial
week of each 4 week period. Progress was checked through
personal contact on a weekly basis. At each exercise testing
session all participants were provided with an evaluation of
their results.
Both groups were provided with the Godin Leisure Time
Questionnaire [22] to record in arbitrary units any addi-
tional physical activity or exercise that was above the pre-
scribed programme. On entering the study participants
were asked to complete a typical retrospective week of the
same questionnaire. This was to ensure that all individu-
als from both groups participated in similar amounts of
physical activity or exercise at baseline. The control group
was offered the intervention at the end of the trial.
Outcomes
The primary outcomes were changes in peak oxygen con-
sumption (VO2 peak), submaximal oxygen consumption at
2 minutes (2minVO2) and 4 minutes (4minVO2), and bio-
logical markers of inflammation (C-reactive protein, IL-6
and TNFα) between baseline and post intervention. Sec-
ondary outcomes were changes in time to exhaustion, rest-
ing heart rate, systolic and diastolic blood pressure.
Secondary biological markers were fasting glucose and total
cholesterol. Secondary physical outcomes were changes in
body weight and body mass index (BMI). All outcome
measures were taken after a 24 hour period of no exercise.
Biological outcomes
Fasting blood samples were collected in the morning,
before any of the physiological tests. Whole blood samples
were analysed for total cholesterol and glucose using an
Abbott 8200 analyser (Abbott, Chicago, IL, USA). Choles-
terol and glucose levels were measured using the choles-
terol oxidase and hexokinase method respectively. Serum
samples were used for CRP, TNFα, and IL-6. These were
separated by low-speed centrifugation, and stored for later
analysis at -70°C. The assays were performed using a semi-
automated solid-phase, enzyme-labelled, chemilumines-
cent sequential immunometric assay (Euro/DPC, Gwyn-
edd, UK), and measured using an IMMULITE 1000
analyser (Immulite, Gwynedd, UK). The lowest detection
levels for IL-6, TNFα and CRP were 2 pg/mL, 1.7 pg/mL and
0.1 mg/L respectively. For the purpose of data analysis all
values below the detection limit were coded as 1.9 pg/mL,
1.6 pg/mL and 0.05 mg/L respectively.
Blood pressure
Subjects remained in the supine position for 10 minutes.
Blood pressure was measured manually, and recorded to
Schematic experimental time-line of the aerobic exercise training intervention programmeFigure 1
Schematic experimental time-line of the aerobic exercise training intervention programme.
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evaluation) 
Exercise prescription 
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Exercise prescription 
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assessment
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week 8-12: Individual
maintenance of 
programme at week 8 
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three times then averaged.
Physical characteristics
Body composition was assessed indirectly through
changes in body weight and body mass index. Body
weight was assessed using an electronic scale (Seca, Vogel
Halke, Germany). Standing height was determined with-
out shoes. Body mass index was calculated as body mass
(Kg) divided by height squared (m2).
Cardiopulmonary outcomes
Cardiopulmonary outcomes were evaluated using a pro-
gressive walking test (modified Bruce protocol) to voli-
tional fatigue on a motorised treadmill. Speed (2.5, 3, 3.5
or 4 m·p-1· h-1) was predetermined by the participant's
previous exercise history, and remained constant for the
duration of the test, and for each subsequent test. The gra-
dient was set at 2 % and increased by 1 % each minute.
Heart rate data were recorded at 1-minute intervals. On
the initial test this was used with VO2 data to determine
the heart rate training intensity (65 % VO2 peak) of the
exercise-training programme. This procedure was
repeated at 4 and 8 weeks to ensure correct continuation
of the heart rate training prescription. Participants were
provided with standardized encouragement throughout
the test.
Criteria for peak oxygen consumption included any two
of the following: a peak or plateau for more than 1 minute
in oxygen consumption; a respiratory exchange ratio ≥
1.15; volitional exhaustion; and rating of perceived exer-
tion greater than 19 (Borg, 1980). Exercise was terminated
if participants developed severe dyspnea, dizziness, or
chest pain, or had an abnormal heart rate response.
Expired gases were analysed every 5 seconds using an
automated online gas analyser (Oxycon, Jaeger, Hoech-
berg, Germany). The system was calibrated for volume
and gas concentrations before the start of each test. Peak
oxygen consumption and oxygen consumption at 2 and
4-minute intervals were determined by taking the mean of
twelve consecutive 5-second values at the end of each
respective stage. Participants were asked to follow the
same diet for the 24 hour period preceding each testing
session.
Statistical analysis
Baseline characteristics between groups were compared
using independent-samples t tests. Cardiopulmonary out-
comes were normalized to baseline, and expressed as per-
centage change. Due to skewed distribution CRP data was
log transformed. Repeated measures ANOVA were used to
determine differences in outcomes between groups. Post
hoc analysis was made within groups between each time-
point. Where significant interaction effects were found,
post hoc analysis was made at each time point between
groups. SPSS version 14.0 (SPSS Inc, Chicago, IL, USA)
was used for all statistical analyses. A P value < 0.05 was
considered to be statistically significant. The results are
reported as mean ± SD values.
Table 1: Baseline characteristics of exercise and control groups
Characteristic Exercise Group (n = 12) Control Group (n = 8) ≠ P value
Age (yrs) 41 ± 8 42 ± 8 0.460
Weight (kg) 68.5 ± 12.1 66.4 ± 13.2 0.659
BMI 25.9 ± 4.4 26 ± 4.1 0.777
Diastolic BP (mm Hg) 73 ± 10 69 ± 9 0.569
Systolic BP (mm Hg) 118 ± 12 106 ± 10 0.082
Resting heart rate (bpm) 66 ± 9 67 ± 11 0.821
Peak heart rate (bpm) 179 ± 14 182 ± 11 0.893
Time to exhaustion (min) 11.1 ± 3.5 10.7 ± 2.1 0.796
VO2 peak (L·min-1) 2.31 ± 0.65 2.00 ± 0.58 0.244
VO2 peak (mL·kg·min-1) 33.7 ± 8.8 35.5 ± 8.6 0.593
2 min oxygen consumption (L·min-1) 1.6 ± 0.49 1.3 ± 0.35 0.099
2 min oxygen consumption (mL·kg·min-1) 23.1 ± 5.2 20.4 ± 4.6 0.202
4 min oxygen consumption (L·min-1) 1.6 ± 0.36 1.4 ± 0.40 0.524
4 min oxygen consumption (mL·kg·min-1) 23.9 ± 4.5 23.0 ± 4.5 0.200
Past exercise (Godin arbitary units) 6.5 ± 4 7.5 ± 5.5 0.893
Total Cholesterol (mmol/L) 5.13 ± 1.0 4.97 ± 0.9 0.728
Glucose (mmol/L) 5.04 ± 0.50 5.11 ± 0.52 0.763
C-reactive protein (mg/L) 3.05 ± 4.37 3.16 ± 4.73 0.689
Interleukin-6 (pg/mL) 3.21 ± 0.91 3.26 ± 1.08 0.479
TNF-α (pg/L) 12.07 ± 3.27 9.84 ± 2.59 0.082
*Data are presented as mean (SD).Page 4 of 10
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Baseline characteristics
Table 1 presents the baseline characteristics of the exercise
(n = 12) and the control (n = 8) groups. There were no sig-
nificant differences between groups for baseline character-
istics.
Adherence to the exercise training intervention
The exercise group completed 81 ± 14 % (13 ± 2), 84 ± 12
% (13 ± 2) and 70 ± 13 % (11 ± 2) of the 16 prescribed
exercise sessions between week 1 and week 4, week 4 and
week 8, and week 8 and week 12 respectively. Non-proto-
col related exercise was not significantly different between
groups at any time point during the study (week 4 P =
0.893; week 8 P = 0.952; week 12 P = 0.941).
Changes in cardiopulmonary function
Table 2 and 3 present the cardiopulmonary outcomes.
There was no significant time effect (F = 1.752; P = 0.167)
in VO2 peak (L·min-1), but there was a significant interaction
effect (F = 8.351; P = 0.000) and a treatment effect (F =
25.147; P = 0.000) between exercise and control groups.
Post hoc analysis revealed that there were significant differ-
ences between exercise and control groups at all time points
tested (P = 0.001; P = 0.001; P = 0.000). Furthermore, in the
exercise group VO2 peak (L·min-1) significantly increased
between week 0 and week 4 (P = 0.012), while in the con-
trol group it significantly decreased between week 0 and
week 4 (P = 0.026), week 0 and week 8 (P = 0.004) and
week 0 and 12 (P = 0.001) respectively. However, while
there were no significant differences in peak heart rate
(HRP) from baseline to any of the time points tested in the
exercise group, HRP in the control group was significantly
lower at all time points (P = 0.015; P = 0.032; P = 0.001).
There was no significant time effect in time to exhaustion
(TE) (F = 1.283; P = 0.334), but there were significant inter-
action and treatment effects between the exercise and the
control conditions (F = 4.239; P = 0.006; F = 12.289; P =
0.002). Post hoc analysis between groups revealed signifi-
cant differences at weeks 4 (P = 0.003), 8 (P = 0.002) and
12 (P = 0.036) respectively. Furthermore in the exercise
group TE significantly increased from week 0 – week 4 (P =
0.005), week 0 – week 8 (P = 0.002) and week 0 – week 12
(P = 0.025), but no significant changes occurred in the con-
trol group at any time point.
There was a significant time (F = 12.099; P = 0.000), and
treatment (F = 5.456; P = 0.031) effect in % change for
Table 2: Effects of the exercise-training programme on physiological outcomes from baseline – exercise group (n = 12); control group 
(n = 8)
% Δ Week 1 – 4 % Δ Week 1 – 8 % Δ Week 1 – 12
Variable Exercise 
(mean ± SD)
Control 
(mean ± SD)
Difference 
between 
groups
Exercise 
(mean ± SD)
Control 
(mean ± SD)
Difference 
between 
groups
Exercise 
(mean ± SD)
Control 
(mean ± SD)
Difference 
between 
groups
Peak oxygen 
consumption 
(mL·min)
5.8 ± 6.3
P = 0.012
(122 ± 142)
-3.7 ± 4.4
P = 0.026 
(-69 ± 80)
P≠ = 0.001 5.0 ± 8.7 
P = 0.032 
(137 ± 190)
-6.0 ± 5.8
P = 0.004 
(-107 ± 93)
P≠ = 0.001 2.1 ± 8.5 
P = 0.105 
(103 ± 208)
-8.2 ± 5.4 
P = 0.001 
(-153 ± 105)
P≠ = 0.000
Peak oxygen 
consumption 
(mL·kg·min-1)
6.0 ± 7.2
P = 0.029 
(1.6 ± 2.2)
-4.8 ± 3.3 
P = 0.005 
(-1.4 ± 0.9)
P≠ = 0.000 5.3 ± 10.0 
P = 0.063 
(1.8 ± 3.2)
-5.8 ± 5.2 
P = 0.002 
(-1.7 ± 1.5)
P≠ = 0.003 1.6 ± 9.9
P = 0.200 
(1.3 ± 3.8)
-8.9 ± 5.0 
P = 0.350
(-2.8 ± 1.9)
P≠ = 0.001
Time to exhaustion 
(min)
12.5 ± 12.5 
P = 0.005
(1.1 ± 1.7)
-6.9 ± 12.2
P = 0.157
(-0.6 ± 1.2)
P≠ = 0.003 16.7 ± 14.7
P = 0.002 
(1.5 ± 1.6)
-7.9 ± 14.0
P = 0.158 
(-0.9 ± 1.7)
P≠ = 0.002 16.5 ± 22.0 
P = 0.025 
(1.4 ± 3.0)
-3.6 ± 14.6 
P = 0.506 
(-0.48 ± 1.42)
P≠ = 0.036
Peak heart rate (bpm) 0.1 ± 2.5
P = 0.872 
(0 ± 4)
-1.7 ± 1.5 
P = 0.015 
(3 ± 3)
P≠ = 0.072 -1.07 ± 3.79 
P = 0.291 
(-2 ± 7)
-2.43 ± 2.56 
P = 0.032 
(-5 ± 5)
P≠ = 0.405 0.01 ± 3.34 
P = 0.931 
(0 ± 6)
-2.74 ± 1.46 
P = 0.001 
(-5 ± 3)
P≠ = 0.045
2 min oxygen 
consumption 
(mL·min)
-10.2 ± 10.3 
P = 0.006 
(-140 ± 144)
-1.2 ± 8.1 
P = 0.696 
(-20 ± 96)
P≠ = 0.000 -16.8 ± 10.6 
P = 0.000 
(-250 ± 148)
-6.3 ± 11.6 
P = 0.170 
(-73 ± 136)
P≠ = 0.003 -15.1 ± 8.7 
P = 0.000 
(-231 ± 126)
-5.9 ± 11.9 
P = 0.159 (
-66 ± 145)
P≠ = 0.001
2 min oxygen 
consumption 
(mL·kg·min-1)
-9.8 ± 9.2 
P = 0.004 
(-2.1 ± 1.9)
-2.3 ± 8.3 
P = 0.453 
(-0.5 ± 1.6)
P≠ = 0.000 -16.9 ± 9.2 
P = 0.000 
(-3.7 ± 1.7)
-6.2 ± 12.2 
P = 0.191 
(-1.3 ± 2.4)
P≠ = 0.003 -16.0 ± 5.6 
P = 0.000 
(-3.5 ± 1.6)
-6.6 ± 12.5 
P = 0.178 
(-1.4 ± 2.5)
P≠ = 0.001
4 min oxygen 
consumption (L·min)
-5.4 ± 10.9 
P = 0.068 
(-85 ± 149)
1.9 ± 4.7 
P = 0.289 
(26 ± 68)
P≠ = 0.033 -10.7 ± 7.9 
P = 0.002 
(-162 ± 141)
-1.3 ± 3.9 
P = 0.836 
(-14 ± 51)
P≠ = 0.009 -6.8 ± 9.2 
P = 0.021 
(-116 ± 153)
-4.6 ± 9.2 
P = 0.346 
(57 ± 121)
P≠ = 0.412
4 min oxygen 
consumption 
(mL·kg·min-1)
-5.3 ± 9.3 
P = 0.036 
(-1.4 ± 1.9)
0.64 ± 5.4 
P = 0.746 
(0.2 ± 1.1)
P≠ = 0.071 -11.2 ± 6.7 
P = 0.000 
(-2.6 ± 1.6)
-1.22 ± 4.5 
P = 0.471 
(-0.2 ± 1.0)
P≠ = 0.003 -7.8 ± 8.7 
P = 0.056 
(-1.9 ± 1.9)
-5.4 ± 10.1 
P = 0.173 
(-1.3 ± 2.2)
P≠ = 0.414
Resting heart rate 
(bpm)
-2.5 ± 7.3 
P = 0.261 
(-2 ± 4)
-2.1 ± 9.2 
P = 0.534 
(-2 ± 6)
P≠ = 0.923 -3.0 ± 6.4 
P = 0.149 
(-2 ± 4)
-6.2 ± 7.7 
P = 0.057 
(-5 ± 5)
P≠ = 0.407 -2.2 ± 7.5 
P = 0.335 
(-2 ± 5)
-1.7 ± 11.1 
P = 0.671 
(-2 ± 7)
P≠ = 0.918
Systolic BP (mm Hg) -1.0 ± 4.9 
P = 0.508 
(-1.0 ± 5.7)
-1.0 ± 2.4 
P = 0.266 
(-1.0 ± 2.4)
P≠ = 0.984 -2.0 ± 6.3 
P = 0.293 
(-2.3 ± 7.9)
-0.1 ± 3.9 
P = 0.938 
(0.0 ± 3.8)
P≠ = 0.459 -2.0 ± 6.6 
P = 0.309 
(-2.4 ± 8.0)
-0.3 ± 5.7 
P = 0.888 
(0.0 ± 6.1)
P≠ = 0.553
Diastolic BP (mm Hg) -0.5 ± 5.9 
P = 0.793 
(-0.3 ± 4.4)
0.4 ± 4.5 
P = 0.767 
(0.1 ± 3.5)
P≠ = 0.704 -2.0 ± 6.4 
P = 0.300 
(-0.3 ± 4.4)
-0.7 ± 7.7 
P = 0.809 
(0.1 ± 3.5)
P≠ = 0.682 -2.2 ± 6.6 
P = 0.268 
(-1.8 ± 4.7)
-2.8 ± 5.8 
P = 0.206 
(-1.8 ± 4.1)
P≠ = 0.829
P value for difference in change within groups between 2 time points
P≠ value for difference in change between groups at each time pointPage 5 of 10
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= 2.385; P = 0.079). Post hoc analysis between groups
revealed that significant differences occurred at weeks 4 (P
= 0.000), 8 (P = 0.003) and 12 (P = 0.001) respectively.
While post hoc analysis within groups showed significant
reductions in the exercise group between week 0 and week
4 (P = 0.006), week 4 and week 8 (P = 0.019), week 0 and
week 8 (P = 0.000), and week 0 and week 12 (P = 0.000)
in the exercise group, but no significant changes within
the control group at any time point.
There were significant time (F = 4.004; P = 0.012) and treat-
ment effects (F = 4.803; P = 0.042), but no significant inter-
action effect (F = 2.705; P = 0.054) in % change for absolute
4minVO2. Post hoc analysis between groups revealed that
significant differences occurred at weeks 4 (P = 0.033) and
8 (P = 0.009), but not at week 12. Significant reductions
occurred in the exercise group between week 4 and week 8
(P = 0.038), week 0 and week 8 (P = 0.002), week 8 and
week 12 (P = 0.049) and week 0 and week 12 (P = 0.021),
but not between week 0 and week 4. No significant changes
occurred at any time point in the control group.
Changes in body composition and blood pressure
No significant time, treatment or interaction effects were
observed for BMI (time F = 0.894; P = 0.364; treatment F
= 0.468; P = 0.468; interaction F = 0.034; P = 0.857),
weight (time F = 0.967; P = 0.389; treatment F = 0.501; P
= 0.607; interaction F = 0.211; P = 0.652), systolic blood
pressure (time F = 0.314; P = 0.746; treatment F = 1.657;
P = 0.214; interaction F = 0.469; P = 0.641) or diastolic
blood pressure (time F = 1.483; P = 0.229; treatment F =
0.293; P = 0.595; interaction F = 0.151; P = 0.929) over the
12 week intervention period.
Changes in blood parameters
Table 4 and 5 present blood parameter outcomes. No sig-
nificant time, treatment or interaction effects were
observed for total cholesterol (time F = 0.145; P = 0.932;
treatment F = 0.049; P = 0.827; interaction F = 0.769; P =
0.516), glucose (time F = 0.209; P = 0.890; F = 0.049; P =
0.827; F = 0.615; P = 0.608), IL-6 (time F = 0.877; P =
0.429; F = 2.482; P = 0.133; F = 1.326; P = 0.278) or TNF-
α (time F = 0.057; P = 0.982; treatment F = 0.002; P =
0.961; interaction F = 1.180; P = 0.326) over the 12 week
intervention period. However while there was no signifi-
cant time or treatment effect for CRP in exercise and con-
trol groups (time F = 1.703; P = 0.201; treatment F =
0.189; P = 0.669), there was a significant interaction effect
(F = 3.309; P = 0.027). Post-hoc analysis revealed that
there were no significant differences between exercise and
control groups at any of the time points tested. However
there were significant reductions in CRP within the exer-
cise group between week 1 and week 4 (P = 0.013), week
4 and week 8 (P = 0.000), and between week 1 and week
8 (P = 0.010), while there was no significant change at any
Table 3: Effects of the exercise-training programme on physiological outcomes from interim time point – exercise group (n = 12); 
control group (n = 8)
% Δ Week 4 – 8 % Δ Week 8 – 12
Variable Exercise (mean ± SD) Control (mean ± SD) Exercise (mean ± SD) Control (mean ± SD)
Peak oxygen consumption 
(mL·min)
0.6 ± 5.0 
P = 0.627 (15 ± 101)
-2.1 ± 8.5 
P = 0.377 (-38 ± 154)
-1.3 ± 6.4 
P = 0.377 (-33 ± 159)
-1.6 ± 7.9 
P = 0.389 (-46 ± 166)
Peak oxygen consumption 
(mL·kg·min-1)
0.6 ± 5.8 
P = 0.693 (0.1 ± 2.0)
1.0 ± 7.3 
P = 0.015 (-0.3 ± 2.0)
-2.0 ± 9.6 
P = 0.424 (-0.4 ± 2.8)
-2.9 ± 9.6 
P = 0.685 (-1.1 ± 2.9)
Time to exhaustion (min) 4.0 ± 9.2 
P = 0.190 (0.4 ± 1.0)
-0.5 ± 13.9 
P = 0.826 (-0.2 ± 1.2)
-0.7 ± 12.8 
P = 0.953 (-1.3 ± 1.8)
6.6 ± 22.9 
P = 0.559 (0.3 ± 1.7)
Peak heart rate (bpm) -1.28 ± 2.5 
P = 0.096 (-2 ± 4)
-0.7 ± 2.5 
P = 0.439 (-1 ± 5)
1.1 ± 1.7 
P = 0.051 (2 ± 3)
-0.2 ± 1.9 
P = 0.686 (-1 ± 4)
2 min oxygen consumption 
(mL·min)
-7.1 ± 8.3 
P = 0.019 (-110 ± 146)
-5.0 ± 11.1 
P = 0.217 (-53 ± 129)
2.4 ± 6.3 
P = 0.275 (19 ± 73)
0.6 ± 7.9 
P = 0.948 (7 ± 87)
2 min oxygen consumption 
(mL·kg·min-1)
-7.8 ± 8.6 
P = 0.113 (-1.6 ± 1.8)
-4.0 ± 10.1 
P = 0.286 (-0.8 ± 1.8)
1.9 ± 6.8 
P = 0.363 (0.2 ± 1.2)
-0.2 ± 7.9 
P = 0.902 (-0.1 ± 1.4)
4 min oxygen consumption 
(L·min)
-4.6 ± 7.0 
P = 0.038 (-77 ± 136)
-2.9 ± 6.5 
P = 0.398 (-39 ± 84)
3.6 ± 5.8 
P = 0.049 (47 ± 78)
-3.1 ± 11.3 
P = 0.441 (-43 ± 146)
4 min oxygen consumption 
(mL·kg·min-1)
-5.2 ± 6.9 
P = 0.023 (-1.2 ± 1.7)
-1.7 ± 5.7 
P = 0.381 (-0.4 ± 1.2)
3.4 ± 5.6 
P = 0.009 (0.6 ± 1.0)
-4.0 ± 11.7 
P = 0.339 (-1.0 ± 2.5)
Resting heart rate (bpm) -0.1 ± 9.7 
P = 0.846 (0 ± 6)
-3.7 ± 8.6 
P = 0.254 (-3 ± 6)
1.1 ± 7.6 
P = 0.700 (0 ± 5)
4.8 ± 9.0 
P = 0.164 (3 ± 5)
Systolic BP (mm Hg) -1.0 ± 5.3 
P = 0.537 (-1.3 ± 7.0)
-0.9 ± 2.7 
P = 0.368 (1.0 ± 2.9)
0.1 ± 4.5 
P = 0.989 (-0.1 ± 5.1)
-0.2 ± 4.8 
P = 0.915 (0.0 ± 5.1)
Diastolic BP (mm Hg) -1.3 ± 6.3 
P = 0.462 (-1.3 ± 5.3)
-1.2 ± 4.0 
P = 0.455 (-0.7 ± 4.1)
-0.1 ± 5.6 
P = 0.905 (-0.2 ± 4.2)
-1.6 ± 9.5 
P = 0.539 (-1.2 ± 4.6)
P value for difference in change within groups between 2 time pointsPage 6 of 10
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decrease in TNF-α from baseline within the exercise group
compared to the control group.
Discussion
The data from the study confirmed that a moderate inten-
sity aerobic exercise-training programme performed 4
times a week could be successfully implemented within
the workplace during working hours. Furthermore, it was
demonstrated that it was effective at reducing risk factors
associated with cardiovascular disease, and at improving
physiological capacity within previously sedentary indi-
viduals. Specifically, significant improvements were
found in peak oxygen consumption (VO2 peak), economy
of absolute oxygen utilization at both 2 minutes
(2minVO2) and 4 minutes (4minVO2), and C-reactive
protein (CRP) concentration. These results confirm previ-
ous reports showing that improved cardiovascular fitness,
or physical activity level reduces cardiovascular risk, with
a particular association with lower CRP levels [9,23,24].
This is the first report combining objective physiological
outcome measures with objective monitoring of the train-
ing programme to demonstrate the type of exercise that
can be effectively carried out during working hours, while
still providing health related benefits.
At the end of the 8-week intervention period absolute VO2
peak increased significantly by 5 % in the exercise group,
while it decreased significantly by 6 % in the control
group. There was no significant change in peak heart rate
in the exercise group, but there was a significant reduction
in peak heart rate in the control group, suggesting that a
Table 4: Effects of the exercise-training programme on blood parameters from baseline – exercise group (n = 12); control group (n = 8)
Δ Week 1 – 4 Δ Week 1 – 8 Δ Week 1 – 12
Variable Exercise 
(mean ± 
SD)
Control 
(mean ± 
SD)
Difference 
between 
groups
Exercise 
(mean ± 
SD)
Control 
(mean ± 
SD)
Difference 
between 
groups
Exercise 
(mean ± 
SD)
Control 
(mean ± 
SD)
Difference 
between 
groups
Total 
Cholesterol 
(mmol/L)
0.0 ± 0.6 
P = 0.827
0.0 ± 0.5 
P = 0.880
P≠ = 0.688 -0.2 ± 0.4 
P = 0.136
0.1 ± 0.3 
P = 0.590
P≠ = 0.771 0.0 ± 0.4 
P = 0.967
0.0 ± 0.5 
P = 0.944
P≠ = 0.692
Total Glucose 
(mmol/L)
0.1 ± 1.0 
P = 0.416
-0.1 ± 0.4 
P = 0.943
P≠ = 0.934 0.0 ± 0.8 
P = 0.912
0.1 ± 0.6 
P = 0.450
P≠ = 0.511 -0.1 ± 0.9 
P = 0.936
-0.2 ± 0.6 
P = 0.844
P≠ = 0.760
IL-6 (pg/L) -0.3 ± 1.0 
P = 0.269
0.7 ± 0.8 
P = 0.038
P≠ = 0.939 -0.7 ± 2.0 
P = 0.231
0.3 ± 1.2 
P = 0.553
P≠ = 0.974 0.2 ± 1.2 
P = 0.660
-0.1 ± 0.7 
P = 0.840
P≠ = 0.324
TNF-α (pg/L) -0.9 ± 1.3 
P = 0.032
0.8 ± 2.4 
P = 0.363
P≠ = 0.448 -0.9 ± 1.7 
P = 0.102
0.3 ± 1.6 
P = 0.663
P≠ = 0.297 -0.9 ± 1.6 
P = 0.086
0.3 ± 1.3 
P = 0.567
P≠ = 0.268
CRP (mg/L)* -0.4 ± 0.6 
P = 0.013
-0.3 ± 0.9 
P = 0.526
P≠ = 0.585 -0.9 ± 0.8 
P = 0.010
-0.4 ± 1.3 
P = 0.127
P≠ = 0.224 -1.2 ± 1.5 
P = 0.823
0.1 ± 0.7 
P = 0.836
P≠ = 0.199
P value for difference in change within groups between 2 time points
P≠ value for difference in change between groups at each time point
CRP (mg/L)* P value based on logged data transformation
Table 5: Effects of the exercise-training programme on blood parameters from interim time point – exercise group (n = 12); control 
group (n = 8)
Δ Week 4 – 8 Δ Week 8 – 12
Variable Exercise (mean ± SD) Control (mean ± SD) Exercise (mean ± SD) Control (mean ± SD)
Total Cholesterol 
(mmol/L)
-0.2 ± 0.6 
P = 0.365
0.1 ± 0.3 
P = 0.464
-0.2 ± 0.5 
P = 0.170
-0.1 ± 0.3 
P = 0.667
Total Glucose (mmol/L) -0.1 ± 0.2 
P = 0.195
0.1 ± 0.4 
P = 0.480
0.0 ± 0.2 
P = 0.955
-0.1 ± 0.4 
P = 0.388
IL-6 (pg/L) -0.4 ± 1.2 
P = 0.306
-0.4 ± 1.3 
P = 0.361
0.9 ± 1.5 
P = 0.077
-0.3 ± 0.1 
P = 0.338
TNF-α (pg/L) 0.1 ± 1.5 
P = 0.894
-0.6 ± 1.5 
P = 0.319
0.0 ± 1.7 
P = 0.945
0.0 ± 1.2 
P = 0.977
CRP (mg/L)* -1.0 ± 0.4 
P = 0.000
0.0 ± 0.5 
P = 0.266
-0.5 ± 0.7 
P = 0.101
0.6 ± 1.74 
P = 0.284
P value for difference in change within groups between 2 time points
CRP (mg/L)* P value based on logged data transformationPage 7 of 10
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peak. Absolute 2minVO2 and 4minVO2 decreased signifi-
cantly by 17 % and 11 % respectively in the exercise
group, while there was no significant change in the con-
trol group. Furthermore, as the exercise group averaged
the completion of 81 % and 84 % of the prescribed exer-
cise sessions between week 1 and week 4, and week 4 and
week 8 respectively, it can be concluded that the progres-
sive aerobic exercise training programme was not only
effective at improving the physical fitness of a sedentary
group of adults, but was also successful at increasing phys-
ical activity levels.
However although cardiovascular fitness and physical
activity are positively related, research indicates that it is
the former that is more closely linked to cardiovascular
disease risk factors and disease, than actual physical activ-
ity level [25,26]. As a consequence it has been shown that
it is only those individuals who increase their VO2 max,
rather than their actual physical activity level that reduce
their relative risk of cardiovascular disease risk factors
[27]. This has been attributed to a reduction in large artery
stiffness, which may be mediated by concomitant changes
in high-density lipoprotein (HDL) cholesterol and body
weight [28].
This holds relevance for the present study: after 8 weeks
when the exercise group were not provided with any fur-
ther progression or instruction to the exercise training
programme VO2 peak decreased by 2 %. In view of the 70
% completion of the 16 sessions, and the significant
improvement in absolute 4minVO2 (-7 %), it appears
probable that the intensity of the exercise performed
within this time period was too low to challenge VO2 peak.
This is supported by evidence that indicates that VO2 max
has a modest association with physical activity, but a
much stronger association with the mean intensity of the
exercise [29]. In view of this, and the cardio protective
benefit of an increase in VO2 max future research should
evaluate the implication of a higher intensity workplace
exercise training programme on the modification of cardi-
ovascular risk profile, while assessing whether it remains
successful at ensuring exercise adherence.
It appears that supervision and progression of the exercise
programme may influence adherence [30,31]. In the
present study, at 8 weeks when no further progression or
supervision to the exercise training programme was pro-
vided a reduction in the adherence of the training sessions
occurred; 81 % and 84 % were completed in week 1 to
week 4 and week 4 to week 8, while only 70 % were com-
pleted in week 8 to week 12. This could further highlight
the need for employers to ensure the provision of addi-
tional support and progression to the original training
programme for optimal participation of employees, and
success of the programme.
The exercise group demonstrated a significant decrease in
CRP of -0.4 ± 0.6 mg/L between week 1 and week 4, and -
1.0 ± 0.4 mg/L between week 4 and week 8. However
while this is in accordance with previous research [24,32],
it should be noted that due to a mean baseline value indi-
cating high risk for CVD (> 3.0 mg/L), that the reduction
would still result in a mean value indicating average risk
of CVD (2.2 mg/L) [33]. The mechanism behind such
action remains unclear. It has been postulated that a
reduction in CRP is attained via the positive benefit of
exercise on BMI via modulation of the percentage of vis-
ceral fat and insulin receptor sensitivity [24]. However,
within the present study there was no such positive effect
on body composition, or fasting glucose. Another poten-
tial explanation is that among unfit individuals there is a
greater generation of reactive oxygen species via normal
metabolic processes, and unaccustomed muscle stretch-
ing. This leads to subliminal injury of the myocytes, that
causes both cell and tissue oxidative damage, leading to
an inflammatory response [34]. Evidence confirms that
chronic exercise induces a mechanical resistance of the
myocytes to stretching, and elevates endogenous antioxi-
dant enzyme activity, which prevents excessive local
inflammatory response [35]. As there were significant
gains in aerobic capacity within the exercise group it is
plausible that this explanation provides a mechanism of
action for the observed results.
No significant change was observed in IL-6 at any time
point during the study. However there was a significant
reduction in TNF-α between week 1 and week 4 in the
exercise group. As TNF-α directly impairs glucose uptake
and metabolism via a direct effect on insulin signal trans-
duction, a reduction holds positive benefit for prevention
of CVD [10]. Thus despite the lack of a significant change
in fasting glucose, there is still suggestive evidence that the
training programme may accrue positive benefit for this
specific risk factor.
Although the present study was successful at improving
maximal and submaximal aerobic exercise capacity, it had
no significant effect on fasting glucose or cholesterol,
blood pressure or BMI. It is likely that the small sample
size is responsible for such null findings. However it is
also unsurprising for a number of reasons.
Firstly, although physical activity and exercise improves
insulin sensitivity through a direct effect on the muscle
(enhancement of insulin receptor autophsophorylation
[36], increase in GLUT-4 content [37] and glucose trans-
port-phosphorylation [38], and a reduction in visceral
obesity [39], neither the exercise nor the control groupPage 8 of 10
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0.50; control = 5.11 ± 0.52 mmol/L) at baseline that
would have required intervention modification. The same
can be said for blood pressure, with all participants classi-
fied as normotensive (exercise = 118 ± 12/73 ± 10; control
= 106 ± 10/69 ± 9) at baseline. Nevertheless, in view of the
beneficial effect that exercise has on glucose tolerance,
and evidence that those with low levels of physical fitness
are shown to be at a relative risk of 1.52 for developing
hypertension, when compared to highly fit individuals
[6], the use of exercise in aiding glycemic control, and the
maintenance of healthy blood pressure should still be
encouraged.
Secondly, regarding BMI, it should be considered that the
aim of the training programme was not to directly target
weight loss for a reduction of cardiovascular risk, but
instead to improve physiological capacity, and biomark-
ers of cardiovascular profile. In accordance with this, and
in the absence of dietary modification, it would have been
unlikely that the 4 × 30 minute sessions per week would
have provided the necessary negative energy balance stim-
ulus of 500 – 1000 kcal·d-1 to achieve gradual weight loss
(ACSM, 2006). Given that a BMI ≥ 30 kg·m-2classifies
obesity, concomitantly increasing the risk of hyperten-
sion, poor total cholesterol/HDL cholesterol ratio, coro-
nary disease and mortality rate [40], there is a need for
future work place health promotion programmes to eval-
uate whether an aerobic exercise training programme spe-
cifically targeting weight loss and management as its
primary outcome can be successfully implemented within
the workforce.
A limitation of the present study was the failure to exam-
ine lipoprotein subfractions; small low-density lipopro-
teins (LDLs), high-density lipoproteins (HDLs), high-
density lipoprotein subfractions (HDL3 and HDL2), very
low-density lipoproteins (VLDLs), and respective particle
size, that better reflect CVD risk than absolute measures of
cholesterol concentrations [41]. In a recent study, Halver-
stadt et al (2007) concluded that an aerobic exercise train-
ing program consisting of 20 minutes, 3 days a week,
progressively building up to a duration of 40 minutes and
an intensity of 70 % VO2 max for a period of 24 weeks, plus
a weekend walk was successful at improving lipid subfrac-
tion profile and cardiovascular risk independent of diet
and change in body fat. This is supported by several other
studies, which also indicate an improved plasma lipopro-
tein profile with exercise training, exclusive of weight loss
[5,42].
Conclusion
Our pilot study provides objective and randomised con-
trolled trial data demonstrating that regular supervised
exercise increases physical activity for healthy individuals,
and improves exercise capacity, with a concomitant cardi-
oprotective benefit. As this can be achieved without dis-
rupting the working day, this exercise programme
provides a means of improving health at work. As the
study was conducted within an NHS department, it may
be of particular relevance to the NHS, as the single largest
employer in Europe.
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